Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 28 | $89,680,914 |
| Sells | 54 | $76,223,157 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 21 Aug 2024 16:32 | EYPT | EyePoint Pharmaceuticals Inc | DICICCO WENDY F | Director | 20 Aug 2024 | Purchase | 2,567 | 7.79 | 19,997 | D |
| 21 Aug 2024 16:01 | EYPT | EyePoint Pharmaceuticals Inc | ANDO GORAN | Director | 21 Aug 2024 | Purchase | 5,000 | 7.95 | 39,750 | D |
| 21 Aug 2024 16:01 | EYPT | EyePoint Pharmaceuticals Inc | ZADEREJ KAREN L. | Director | 19 Aug 2024 | Purchase | 12,500 | 7.98 | 99,750 | D |
| 20 Aug 2024 16:04 | EYPT | EyePoint Pharmaceuticals Inc | LURKER NANCY | Director | 16 Aug 2024 | Purchase | 3,173 | 7.88 | 25,003 | D |
| 16 Jul 2024 16:24 | EYPT | EyePoint Pharmaceuticals Inc | GUYER DAVID R | Director | 12 Jul 2024 | Sale | 11,625 | 10.0641 | 116,995 | D |
| 04 Jun 2024 16:28 | EYPT | EyePoint Pharmaceuticals Inc | GUYER DAVID R | Director | 03 Jun 2024 | Sale | 11,625 | 10.2972 | 119,705 | D |
| 16 May 2024 17:19 | EYPT | EyePoint Pharmaceuticals Inc | GUYER DAVID R | Director | 14 May 2024 | Sale | 11,625 | 12.649 | 147,045 | D |
| 08 May 2024 16:23 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 06 May 2024 | Purchase | 207,153 | 12.36 | 2,560,411 | I |
| 08 May 2024 16:23 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 06 May 2024 | Purchase | 642,847 | 11.7 | 7,521,310 | I |
| 22 Apr 2024 16:00 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 18 Apr 2024 | Purchase | 186,521 | 18.9 | 3,525,247 | I |
| 22 Apr 2024 16:00 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 18 Apr 2024 | Purchase | 395,244 | 17.62 | 6,964,199 | I |
| 05 Feb 2024 17:15 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 02 Feb 2024 | Sale | 209 | 28.49 | 5,954 | D |
| 30 Jan 2024 16:53 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 26 Jan 2024 | Sale | 33,665 | 25.7737 | 867,672 | D |
| 30 Jan 2024 16:53 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 26 Jan 2024 | Sale | 15,609 | 25.4066 | 396,572 | D |
| 30 Jan 2024 16:53 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 26 Jan 2024 | Sale | 51 | 25.4066 | 1,296 | D |
| 29 Jan 2024 17:54 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 26 Jan 2024 | Sale | 9,604 | 25.2725 | 242,717 | D |
| 29 Jan 2024 17:54 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 26 Jan 2024 | Sale | 16,413 | 25.4465 | 417,653 | D |
| 29 Jan 2024 17:51 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 25 Jan 2024 | Sale | 300 | 25 | 7,500 | D |
| 29 Jan 2024 17:51 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 25 Jan 2024 | Sale | 300 | 25 | 7,500 | D |
| 26 Jan 2024 17:03 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 25 Jan 2024 | Sale | 300 | 25 | 7,500 | D |
| 26 Jan 2024 17:03 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 25 Jan 2024 | Sale | 300 | 25 | 7,500 | D |
| 26 Jan 2024 17:03 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 24 Jan 2024 | Sale | 5,700 | 25.0094 | 142,554 | D |
| 26 Jan 2024 17:03 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 24 Jan 2024 | Sale | 5,600 | 25.0121 | 140,068 | D |
| 25 Jan 2024 18:26 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 24 Jan 2024 | Sale | 5,651 | 25.0156 | 141,363 | D |
| 25 Jan 2024 18:26 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 24 Jan 2024 | Sale | 5,600 | 25.0093 | 140,052 | D |
| 25 Jan 2024 18:26 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 23 Jan 2024 | Sale | 3,096 | 25 | 77,400 | D |
| 25 Jan 2024 18:26 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 23 Jan 2024 | Sale | 2,039 | 25 | 50,975 | D |
| 25 Jan 2024 18:24 | EYPT | EyePoint Pharmaceuticals Inc | LURKER NANCY | Executive Vice Chair | 24 Jan 2024 | Sale | 29,956 | 24.9783 | 748,250 | D |
| 25 Jan 2024 18:24 | EYPT | EyePoint Pharmaceuticals Inc | LURKER NANCY | Executive Vice Chair | 23 Jan 2024 | Sale | 5,044 | 24.9702 | 125,950 | D |
| 24 Jan 2024 16:50 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 23 Jan 2024 | Sale | 500 | 25 | 12,500 | D |
| 24 Jan 2024 16:50 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 23 Jan 2024 | Sale | 400 | 25 | 10,000 | D |
| 24 Jan 2024 16:50 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 22 Jan 2024 | Sale | 28,750 | 22.6871 | 652,254 | D |
| 24 Jan 2024 16:50 | EYPT | EyePoint Pharmaceuticals Inc | JONES DAVID SCOTT | SVP & Chief Commercial Officer | 22 Jan 2024 | Sale | 5,416 | 22.2373 | 120,437 | D |
| 16 Jan 2024 18:01 | EYPT | EyePoint Pharmaceuticals Inc | LIU YE | Director | 11 Jan 2024 | Sale | 1,910,500 | 19.45 | 37,159,225 | I |
| 11 Jan 2024 16:00 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 11 Jan 2024 | Purchase | 750,000 | 19.75 | 14,812,500 | I |
| 11 Jan 2024 16:00 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 09 Jan 2024 | Purchase | 105,000 | 21.32 | 2,238,600 | I |
| 10 Jan 2024 16:53 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 08 Jan 2024 | Sale | 22,913 | 21.1288 | 484,124 | D |
| 15 Dec 2023 17:14 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 13 Dec 2023 | Sale | 1,458 | 20 | 29,160 | D |
| 12 Dec 2023 16:52 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Dec 2023 | Purchase | 588,235 | 17 | 9,999,995 | I |
| 11 Dec 2023 16:15 | EYPT | EyePoint Pharmaceuticals Inc | PINE MICHAEL CRAIG | Chief Corp Dev.&Strat. Officer | 04 Dec 2023 | Sale A | 1,000 | 20.79 | 20,790 | D |
| 11 Dec 2023 16:15 | EYPT | EyePoint Pharmaceuticals Inc | PINE MICHAEL CRAIG | Chief Corp Dev.&Strat. Officer | 04 Dec 2023 | Sale A | 45,000 | 22 | 990,000 | D |
| 07 Dec 2023 21:03 | EYPT | EyePoint Pharmaceuticals Inc | LIU YE | Director | 06 Dec 2023 | Sale | 266,242 | 18.41 | 4,901,515 | I |
| 07 Dec 2023 21:03 | EYPT | EyePoint Pharmaceuticals Inc | LIU YE | Director | 05 Dec 2023 | Sale | 733,758 | 19.91 | 14,609,122 | I |
| 06 Dec 2023 17:20 | EYPT | EyePoint Pharmaceuticals Inc | PINE MICHAEL CRAIG | Chief Corp Dev.&Strat. Officer | 04 Dec 2023 | Sale | 45,000 | 22 | 990,000 | D |
| 06 Dec 2023 17:19 | EYPT | EyePoint Pharmaceuticals Inc | PAGGIARINO DARIO A. | Chief Medical Officer | 04 Dec 2023 | Sale | 30,625 | 22 | 673,750 | D |
| 06 Dec 2023 17:18 | EYPT | EyePoint Pharmaceuticals Inc | LURKER NANCY | Executive Vice Chair | 04 Dec 2023 | Sale | 20,000 | 20.76 | 415,200 | D |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 8,260 | 34.49 | 284,887 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 19,866 | 33.75 | 670,478 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 41,824 | 33.08 | 1,383,538 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 86,713 | 31.83 | 2,760,075 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 18,601 | 29.91 | 556,356 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 15,582 | 30.74 | 478,991 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 8,168 | 28.78 | 235,075 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 27,425 | 27.87 | 764,335 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 53,109 | 26.73 | 1,419,604 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 65,086 | 25.88 | 1,684,426 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 39,899 | 24.87 | 992,288 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 37,081 | 24.01 | 890,315 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 79,805 | 21.87 | 1,745,335 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 28,090 | 22.8 | 640,452 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 122,625 | 20.62 | 2,528,528 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 945,664 | 19.88 | 18,799,800 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 321,259 | 18.8 | 6,039,669 | I |
| 06 Sep 2023 19:10 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 01 Sep 2023 | Sale A | 20,000 | 9.8991 | 197,982 | I |
| 06 Sep 2023 17:14 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 01 Sep 2023 | Sale | 20,000 | 9.8991 | 197,982 | I |
| 01 Sep 2023 16:51 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 31 Aug 2023 | Sale | 7,017 | 11.0214 | 77,337 | I |
| 01 Sep 2023 16:51 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 31 Aug 2023 | Sale | 71,478 | 10.1671 | 726,724 | I |
| 01 Sep 2023 16:51 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 30 Aug 2023 | Sale | 327 | 11.3595 | 3,715 | I |
| 01 Sep 2023 16:51 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 30 Aug 2023 | Sale | 60,649 | 10.9224 | 662,433 | I |
| 30 Aug 2023 17:46 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 29 Aug 2023 | Sale | 565 | 11.56 | 6,531 | I |
| 30 Aug 2023 17:46 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 29 Aug 2023 | Sale | 87,289 | 10.7424 | 937,693 | I |
| 30 Aug 2023 17:46 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 28 Aug 2023 | Sale | 60,858 | 11.7101 | 712,653 | I |
| 30 Aug 2023 17:32 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 25 Aug 2023 | Sale A | 11,731 | 10.45 | 122,589 | I |
| 30 Aug 2023 17:32 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 25 Aug 2023 | Sale A | 72,925 | 11.09 | 808,738 | I |
| 30 Aug 2023 17:32 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 24 Aug 2023 | Sale A | 52,180 | 10.56 | 551,021 | I |
| 30 Aug 2023 17:32 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 24 Aug 2023 | Sale A | 87,100 | 11.54 | 1,005,134 | I |
| 28 Aug 2023 18:32 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 25 Aug 2023 | Sale | 54,656 | 11.1854 | 611,349 | I |
| 28 Aug 2023 18:32 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 25 Aug 2023 | Sale | 30,000 | 10.671 | 320,130 | I |
| 28 Aug 2023 18:32 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 24 Aug 2023 | Sale | 139,280 | 14.6187 | 2,036,093 | I |
| 24 Aug 2023 17:30 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 23 Aug 2023 | Sale | 121,103 | 13.0543 | 1,580,915 | I |
| 24 Aug 2023 17:30 | EYPT | EyePoint Pharmaceuticals Inc | EW HEALTHCARE PARTNERS, L.P. | 10% | 22 Aug 2023 | Sale | 46,778 | 14.6187 | 683,834 | I |
| 31 May 2023 17:22 | EYPT | EyePoint Pharmaceuticals Inc | LIU YE | Director | 30 May 2023 | Sale | 1 | 6 | 6 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)